Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literature
暂无分享,去创建一个
A. Bonafe | C. Arquizan | V. Costalat | F. Cagnazzo | P. Lefevre | I. Derraz | C. Dargazanli | G. Gascou | C. Riquelme | I. Mourand | N. Gaillard
[1] D. Kaya,et al. Reader response: Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry , 2020 .
[2] C. Oppenheim,et al. Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study , 2020 .
[3] M. Gomez-Beldarrain,et al. Neurological reasons for consultation and hospitalization during the COVID-19 pandemic , 2020, Neurological Sciences.
[4] F. Roser,et al. Characteristics of Large-Vessel Occlusion Associated with COVID-19 and Ischemic Stroke , 2020, American Journal of Neuroradiology.
[5] P. Striano,et al. Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients , 2020, Neurological Sciences.
[6] B. Cucchiara,et al. Acute Cerebrovascular Events in Hospitalized COVID-19 Patients , 2020, Stroke.
[7] C. Oppenheim,et al. Neurologic and neuroimaging findings in COVID-19 patients: A retrospective multicenter study. , 2020, Neurology.
[8] S. Lehéricy,et al. Retrospective Observational Study of Brain Magnetic Resonance Imaging Findings in Patients with Acute SARS-CoV-2 Infection and Neurological Manifestations , 2020, Radiology.
[9] P. Gil,et al. Clinical presentation and outcome across age categories among patients with COVID-19 admitted to a Spanish Emergency Department , 2020, European Geriatric Medicine.
[10] A. Ahmadzadeh,et al. Frequency and outcome of olfactory impairment and sinonasal involvement in hospitalized patients with COVID-19 , 2020, Neurological Sciences.
[11] Marika M. Cusick,et al. Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza. , 2020, JAMA neurology.
[12] S. Paybast,et al. Guillain-Barré Syndrome as a Neurological Complication of Novel COVID-19 Infection , 2020, The neurologist.
[13] Ö. Karadaş,et al. A prospective clinical study of detailed neurological manifestations in patients with COVID-19 , 2020, Neurological Sciences.
[14] P. Matthews,et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study , 2020, The Lancet Psychiatry.
[15] L. Tatu,et al. Guillain–Barré syndrome in the COVID-19 era: another occasional cluster? , 2020, Journal of Neurology.
[16] Josemir W Sander,et al. New onset neurologic events in people with COVID-19 in 3 regions in China , 2020, Neurology.
[17] Imen Megdiche,et al. Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study , 2020, Radiology.
[18] Vasuki H. Dandu,et al. Spectrum of neuropsychiatric manifestations in COVID-19 , 2020, Brain, Behavior, and Immunity.
[19] Deepak L. Bhatt,et al. Prevalence and Outcomes of Acute Ischemic Stroke Among Patients ≤50 Years of Age With Laboratory Confirmed COVID-19 Infection , 2020, The American Journal of Cardiology.
[20] B. Jacobs,et al. Guillain–Barré syndrome after SARS‐CoV‐2 infection , 2020, European journal of neurology.
[21] Pardis C Sabeti,et al. Neuropathological Features of Covid-19 , 2020, The New England journal of medicine.
[22] T. Segura,et al. Neurologic manifestations in hospitalized patients with COVID-19 , 2020, Neurology.
[23] M. Leonardi,et al. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy , 2020, Neurology.
[24] L. Saba,et al. Imaging of Neurologic Disease in Hospitalized Patients with COVID-19: An Italian Multicenter Retrospective Observational Study , 2020, Radiology.
[25] D. Brodie,et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study , 2020, The Lancet.
[26] Simon A. Jones,et al. COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome , 2020, Journal of the Neurological Sciences.
[27] F. Journé,et al. Objective olfactory evaluation of self‐reported loss of smell in a case series of 86 COVID‐19 patients , 2020, Head & neck.
[28] S. Farmer,et al. Characteristics of ischaemic stroke associated with COVID-19 , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.
[29] Thomas J Oxley,et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young , 2020, The New England journal of medicine.
[30] J. Masjuán,et al. Acute‐onset smell and taste disorders in the context of COVID‐19: a pilot multicentre polymerase chain reaction based case–control study , 2020, European journal of neurology.
[31] D. Brodie,et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study , 2020, medRxiv.
[32] Josemir W Sander,et al. New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study , 2020, Epilepsia.
[33] J. Benito-León,et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19 , 2020, Neurology.
[34] F. Cheng,et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China , 2020, Clinical Microbiology and Infection.
[35] A. Green,et al. The Spectrum of Neurologic Disease in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Infection: Neurologists Move to the Frontlines. , 2020, JAMA neurology.
[36] L. Mao,et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. , 2020, JAMA neurology.
[37] R. Carlier,et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study , 2020, European Archives of Oto-Rhino-Laryngology.
[38] J. M. Abduljalil,et al. Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view , 2020, New microbes and new infections.
[39] J. M. Abduljali,et al. Epidemiology, genome and clinical features of the pandemic SARS-CoV-2: a recent view , 2020, New Microbes and New Infections.
[40] Suresh Patel,et al. COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features , 2020, Radiology.
[41] A. Nath. Neurologic complications of coronavirus infections , 2020, Neurology.
[42] Dengju Li,et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy , 2020, Journal of Thrombosis and Haemostasis.
[43] Tao Guo,et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.
[44] Ke Ma,et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study , 2020, BMJ.
[45] Lanjuan Li,et al. Analysis of Epidemiological and Clinical features in older patients with Corona Virus Disease 2019 (COVID-19) out of Wuhan , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[46] Lanjuan Li,et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms , 2020, Gut.
[47] Y. Xiong,et al. Clinical features and treatment of COVID‐19 patients in northeast Chongqing , 2020, Journal of medical virology.
[48] Wei Liu,et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study , 2020, Chinese medical journal.
[49] Rui-guang Zhang,et al. Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[50] Usman Ali,et al. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms , 2020, ACS chemical neuroscience.
[51] Yuxin Shi,et al. Clinical progression of patients with COVID-19 in Shanghai, China , 2020, Journal of Infection.
[52] Y. Xian,et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study , 2020, Stroke and vascular neurology.
[53] P. Espinosa,et al. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy , 2020, Cureus.
[54] Wei Wang,et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis , 2020, European Respiratory Journal.
[55] Shengqing Wan,et al. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations , 2020, Cell Discovery.
[56] Dengju Li,et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.
[57] Chuan Qin,et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[58] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[59] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[60] M. Ciccozzi,et al. The 2019‐new coronavirus epidemic: Evidence for virus evolution , 2020, bioRxiv.
[61] S. Lo,et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.
[62] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[63] Daishi Tian,et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China , 2020 .
[64] N. Gupta,et al. The stimulation of thrombosis by hypoxia. , 2019, Thrombosis research.
[65] M. Weigand,et al. Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study , 2019, Annals of Intensive Care.
[66] S. Marsch,et al. Acute Neurologic Complications During Extracorporeal Membrane Oxygenation: A Systematic Review , 2018, Critical care medicine.
[67] D. Cabrera,et al. Renin‐Angiotensin System: An Old Player with Novel Functions in Skeletal Muscle , 2015, Medicinal research reviews.
[68] A. Hajeer,et al. Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV) , 2015, Infection.
[69] P. Tugwell,et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .
[70] M. Moghadami,et al. The Neurological Manifestations of H1N1 Influenza Infection; Diagnostic Challenges and Recommendations , 2011, Iranian journal of medical sciences.
[71] D. Moher,et al. Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Physical therapy.
[72] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.
[73] David K. Meyerholz,et al. Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2 , 2008, Journal of Virology.
[74] L. Tsai,et al. Neuromuscular disorders in severe acute respiratory syndrome. , 2004, Archives of neurology.
[75] J. Sung,et al. Detection of SARS Coronavirus RNA in the Cerebrospinal Fluid of a Patient with Severe Acute Respiratory Syndrome , 2003, Clinical chemistry.